To begin with, five significantly differentially expressed CXCLs overlapping between GEPIA2 and Oncomine databases were screened out, among which CXCL 9/10 was elevated, while CXCL2/12/14 was decreased in HCC versus normal control. This evidence concerns the gene CXCL2 and hepatocellular carcinoma.